Literatur
Flesch-Janys D, Slanger T, Mutschelknauss E et al (2008) Risk of different histological types of postmenopausal breast cancer by type and regimen of menopausal hormone therapy. Int J Cancer 123(4):933–941
Jung AY, Cai X, Thoene K et al (2019) Antioxidant supplementation and breast cancer prognosis in postmenopausal women undergoing chemotherapy and radiation therapy. Am J Clin Nutr 109(1):69–78
Micke O, Bruns F, Glatzel M, Schönekaes K, Micke P, Mücke R, Büntzel J (2009) Predictive factors for the use of complementary and alternative medicine (CAM) in radiation oncology. Eur J Integr Med 1(1):19–25
Mücke R, Schomburg L, Büntzel J, Gröber U, Holzhauer P, Micke O (2010) Komplementärer Seleneinsatz in der Onkologie. Onkologe 16(2):181–186
Nechuta S, Lu W, Chen Z et al (2011) Vitamin supplement use during breast cancer treatment and survival: A prospective cohort study. Cancer Epidemiol Biomarkers Prev 20(2):262–271
Greenlee H, Kwan ML, Kushi LH et al (2012) Antioxidant supplement use after breast cancer diagnosis and mortality in the life after cancer epidemiology (LACE) cohort. Cancer 118(8):2048–2058
Muecke R, Micke O, Schomburg L et al (2014) Multicenter, phase III trial comparing selenium supplementation with observation in gynecologic radiation oncology: Follow-up analysis of the survival data 6 years after cessation of randomization. Integr Cancer Ther 13(6):463–467
Muecke R, Micke O, Schomburg L et al (2013) Impact of treatment planning target volumen (PTV) size on radiation induced diarrhoea following selenium supplementation in gynecologic radiation oncology—A subgroup analysis of a multicenter, phase III trial. Radiat Oncol 8:72
Muecke R, Schomburg L, Glatzel M et al (2010) Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology. Int J Radiat Oncol Biol Phys 78(3):828–835
Puspitasari IM, Abdulah R, Yamazaki C et al (2014) Updates on clinical studies of selenium supplementation in radiotherapy. Radiat Oncol 9:125
Hübner J, Münstedt K, Mücke R, Micke O (2013) Is there level I evidence for complementary and alternative medicine (CAM) in oncology? An analysis of Cochrane Reviews. Trace Elem Electrolytes 30(1):29–34
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
M.D. Piroth, R. Mücke und O. Micke geben an, dass kein Interessenkonflikt besteht.
Additional information
Originalpublikation
Jung AY, Cai X, Thoene K et al (2019) Antioxidant supplementation and breast cancer prognosis in postmenopausal women undergoing chemotherapy and radiation therapy. Am J Clin Nutr, Jan; 109(1): 69–78
Rights and permissions
About this article
Cite this article
Piroth, M.D., Mücke, R. & Micke, O. Antioxidantien und Selen gehören nicht in einen Topf – Bewertung der Supplementierung während Chemo- oder Strahlentherapie bei Brustkrebs. Strahlenther Onkol 195, 857–860 (2019). https://doi.org/10.1007/s00066-019-01486-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00066-019-01486-x